著作發表

原著論文（第一作者）

1. Ling LC, Lo LW, Chung FP, et al. Skin sympathetic nerve activity after pulsed field pulmonary vein isolation for paroxysmal atrial fibrillation: the NEU-PFA Study. Circ Arrhythm Electrophysiol. 2026.（Research Letter，已接受，in press）
2. Ling LC, Chang TY, Chang SL, et al. Predictors of recurrence and quality of life after cryoballoon ablation in atrial fibrillation: data from a multicenter Taiwanese registry with 24-month follow-up. J Cardiovasc Electrophysiol. 2026.（已接受，in press）
3. Ling LC, Huang WM, Chang HC, et al. Change in dapagliflozin trial eligibility status and prognosis among patients with acute heart failure with preserved ejection fraction. J Chin Med Assoc. 2026;89(3):220-227. doi:10.1097/JCMA.0000000000001349. PMID:41630103.
4. Ling LC, Chang TY, Lin CY, et al. Impact of obesity phenotypes on efficacy and safety of catheter ablation for patients with paroxysmal atrial fibrillation. Acta Cardiol Sin. 2025;41(6):691-702. doi:10.6515/ACS.202511_41(6).20250616E. PMID:41311576.
5. Ling LC, Lin CY, Lin YJ. Epicardial mapping and ablation of ventricular tachycardia in a patient with non-ischemic cardiomyopathy post-thoracotomy cardiovascular surgery and epicardial pacemaker implantation: a case report of challenges. Acta Cardiol Sin. 2025;41(6):800-804. doi:10.6515/ACS.202511_41(6).20250818B. PMID:41311574.
6. Ling LC, Chang TY, Lin YJ, et al. Performance of the novel ANTWERP score in predicting heart function improvement after atrial fibrillation ablation in Asian patients with heart failure. J Arrhythm. 2024;40(6):1359-1369. doi:10.1002/joa3.13162. PMID:39669923.

原著論文（共同作者）

1. Lee CC, Lin CY, Chung FP, … Ling LC, … Chen SA. Utilizing lead aVR QRS morphology to localize abnormal substrates in arrhythmogenic right ventricular cardiomyopathy. Korean Circ J. 2027;57(1):e14. doi:10.4070/kcj.2025.0547.（線上先行）
2. Le XH, Lin CY, Chung FP, … Ling LC, … Chen SA. Premature ventricular contractions from the proximal left anterior fascicle: insight from the electrophysiologic and anatomic parameters. J Cardiovasc Electrophysiol. 2026;37(1):7-16. doi:10.1111/jce.70164. PMID:41146413.
3. Lin CY, et al.（Ling LC 共同作者）. Islands of fractionation for automated fractionation mapping in epicardial Brugada syndrome substrate ablation. Pacing Clin Electrophysiol. 2026.（已接受，in press）

學會摘要（第一作者，11 篇）

• Electrode-spacing–dependent near-field–far-field local activation time difference as a marker of intramural / LVOT PVCs. APSC 2026 — Best Moderated Poster Award得獎
• Post-procedural troponin I surge as a predictor of atrial arrhythmia recurrence after PFA. 台灣心律醫學會（THRS）2026 — Chaired Poster 第三名得獎
• Early recurrence of atrial tachyarrhythmia during the 8-week blanking period after PFA predicts late recurrence: a multicenter registry. Heart Rhythm. 2026;23(4):S223-S224.（HRS 2026）
• Assessment of sympathetic neural activity post-pulsed field ablation: findings from a paroxysmal AF cohort（the NEU-PFA trial）. Heart Rhythm. 2025;22(4):S242.（HRS 2025）
• Modified olive strategy enhances pentaspline PFA outcomes in paroxysmal AF: a multicenter prospective cohort registry. Heart Rhythm. 2025;22(4):S346-S347.（HRS 2025）
• Impact of obesity phenotypes on atrial fibrillation ablation outcomes in an Asian population. Heart Rhythm. 2025;22(4):S351-S352.（HRS 2025）
• Cardiovascular mortality increased in atrial fibrillation patients with high level of physical activity: delineating the threshold of high-level. Heart Rhythm. 2025;22(4):S216-S217.（HRS 2025）
• Longitudinal outcomes of ablation therapy for paroxysmal atrial fibrillation in Asian populations with metabolically distinct obesity profiles. Heart Rhythm. 2024;21(5):S342-S343.（HRS 2024）
• Asymptomatic left ventricular dysfunction in patients with or without type 2 diabetes mellitus: a population-based cohort study. J Am Coll Cardiol. 2023;81(16):S48-S49. TCTAP 2023 — Best Abstract Award得獎
• Outcomes of asymptomatic left ventricular dysfunction in the patient with or without type 2 diabetes mellitus. Eur Heart J. 2023;44(Suppl 2):ehad655.835.（ESC Congress 2023）
• The classification shifting and outcomes of DELIVER-type patients with acute heart failure and preserved ejection fraction. Eur Heart J. 2023;44(Suppl 2):ehad655.1098.（ESC Congress 2023）

學會摘要（共同作者，21 篇，節錄）

• Increased PFA applications lead to greater myocardial injury, inflammation and hemolysis without affecting cardiac autonomic neuron activity. Heart Rhythm. 2025;22(4):S388-S389.（第二作者，HRS 2025）
• PFA reduces AF recurrence without inducing autonomic neural remodeling in the LA. Heart Rhythm. 2025;22(4):S390.（第二作者，HRS 2025）
• 其餘為 HRS 2024–2026 與 EHRA 2024（Europace）共同作者摘要，以心房顫動 PFA、心室頻脈與 Brugada 症候群系列為主。

審稿中

• Modified 4-application olive workflow for pentaspline pulsed-field pulmonary vein isolation in paroxysmal AF（OLIVE-PFA Study，多中心）。
• Cardiovascular mortality in patients with AF and physical activity intensity（vigorous-activity threshold）。

中文文章

• 凌濼傑、李慶威。主動脈瓣狹窄之介紹與現行治療指引——根據美國及歐洲心臟醫學會發佈之治療指引。臨床醫學月刊. 2023;91(1):42-47.